Pigment epithelium-derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells

Stem Cells

Volumn 31, Issue 12, 2013, Pages 2714-2723

  Li, Feng ^a   Song, Na ^a   Tombran Tink, Joyce ^b   Niyibizi, Christopher ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b Division of Musculoskeletal Sciences   (United States)

Author keywords

Adult stem cells; Bone; Differentiation; MAPK; Mesenchymal stem cells; Osteoblast; PEDF

Indexed keywords

ALKALINE PHOSPHATASE; BETA ACTIN; BONE MORPHOGENETIC PROTEIN 2; BONE SIALOPROTEIN; COLLAGEN TYPE 1; MINERAL; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; OSTEOPONTIN; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MINERALIZATION; MULTIPOTENT STEM CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; AGED; ANIMAL; BONE; BONE MINERALIZATION; CELL CULTURE; CELL GROWTH; CYTOLOGY; ENZYMOLOGY; FEMALE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; MOUSE; PHYSIOLOGY; SCID MOUSE;

AGED; ANIMALS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELLS, CULTURED; EYE PROTEINS; FEMALE; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, SCID; MIDDLE AGED; NERVE GROWTH FACTORS; OSTEOBLASTS; PROTO-ONCOGENE PROTEINS C-AKT; SERPINS;

EID: 84890532945     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1505     Document Type: Article

References (59)

1. Dawson DW, Volpert OV, Gillis P et al. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 1999;285:245-248.
2. Cai J, Jiang WG, Grant MB et al. Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 2006;281:3604-3613.
3. Chung C, Doll JA, Stellmach VM et al. Pigment epithelium-derived factor is an angiogenesis and lipid regulator that activates peroxisome proliferator-Activated receptor alpha. Adv Exp Med Biol 2008;617: 591-597.
4. Tombran-Tink J, Chader GG, Johnson LV. PEDF: A pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991;53:411-414.
5. Steele FR, Chader GJ, Johnson LV et al. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA 1993;90: 1526-1530.
6. Ho TC, Chen SL, Shih SC et al. Pigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cells. Am J Pathol 2010;177:1798-1811.
7. Quan GM, Ojaimi J, Li Y et al. Localization of pigment epitheliumderived factor in growing mouse bone. Calcif Tissue Int 2005;76:146-153.
8. Aparicio S, Sawant S, Lara N et al. Expression of angiogenesis factors in human umbilical vein endothelial cells and their regulation by PEDF. Biochem Biophys Res Commun 2005;326:387-394.
9. Apte RS, Barreiro RA, Duh E et al. Stimulation of neovascularization by the anti-Angiogenic factor PEDF. Invest Ophthalmol Vis Sci 2004; 45:4491-4497.
10. Bai YJ, Huang LZ, Zhou AY et al. Antiangiogenesis effects of endostatin in retinal neovascularization. J Ocul Pharmacol Ther.2013 [Epub ahead of print]..
11. Becerra SP, Notario V. The effects of PEDF on cancer biology: Mechanisms of action and therapeutic potential. Nat Rev Cancer 2013;13: 258-271.
12. Becker J, Semler O, Gilissen C et al. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 2011;88:362-371.
13. Rauch F, Husseini A, Roughley P et al. Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI. J Clin Endocrinol Metab 2012;97:E1550-1556.
14. Venturi G, Gandini A, Monti E et al. Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen. J Bone Miner Res 2012;27:723-728.
15. Homan EP, Rauch F, Grafe I et al. Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res 2011;26:2798-2803.
16. Kawamura K, Chu CR, Sobajima S et al. Adenoviral-mediated transfer of TGF-beta1 but not IGF-1 induces chondrogenic differentiation of human mesenchymal stem cells in pellet cultures. Exp Hematol 2005; 33:865-872.
17. Li F, Wang X, Niyibizi C. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Stem Cells 2007;25: 3183-3193.
18. Barry F, Boynton RE, Liu B et al. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation-dependent gene expression of matrix components. Exp Cell Res 2001;268:189-200.
19. Maddox JR, Ludlow KD, Li F et al. Breast and abdominal adipose multipotent mesenchymal stromal cells and stage-specific embryonic antigen 4 expression. Cells Tissues Organs 2012;196:107-116.
20. Bi Y, Ehirchiou D, Kilts TM et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007;13:1219-1227.
21. Kuznetsov SA, Mankani MH, Robey PG. Effect of serum on human bone marrow stromal cells: exvivo expansion and in vivo bone formation. Transplantation 2000;70:1780-1787.
22. Krebsbach PH, Kuznetsov SA, Satomura K et al. Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 1997;63:1059-1069.
23. Liu Y, Leo LF, McGregor C et al. Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice. Mol Med 2012;18:1387-1401.
24. Li F, Wang X, Niyibizi C. Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. Bone 2010;47:546-555.
25. Cheung LW, Au SC, Cheung AN et al. Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells. Endocrinology 2006;147:4179-4191.
26. Volpert KN, Tombran-Tink J, Barnstable C et al. PEDF and GDNF are key regulators of photoreceptor development and retinal neurogenesis in reaggregates from chick embryonic retina. J Ocul Biol Dis Infor 2009;2:1-11.
27. D'Ippolito G, Schiller PC, Ricordi C et al. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999;14:1115-1122.
28. Song L, Tuan RS. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 2004;18:980-982.
29. Li F, Bronson S, Niyibizi C. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. J Cell Biochem 2010;109:643-652.
30. Kornprat P, Langner C, Mohadjer D et al. Chicken-bone perforation of a sigmoid colon diverticulum into the right groin and subsequent phlegmonous inflammation of the abdominal wall. Wien Klin Wochenschr 2009;121:220-222.
31. Horwitz EM, Le Blanc K, Dominici M et al. Clarification of the nomenclature for MSC: The International Society for cellular therapy position statement. Cytotherapy 2005;7:393-395.
32. Tombran-Tink J. PEDF in angiogenic eye diseases. Curr Mol Med 2010;10:267-278.
33. Hoshina D, Abe R, Yamagishi SI et al. The role of PEDF in tumor growth and metastasis. Curr Mol Med 2010;10:292-295.
34. Tombran-Tink J, Aparicio S, Xu X et al. PEDF and the serpins: Phylogeny, sequence conservation, and functional domains. J Struct Biol 2005;151:130-150.
35. Perez-Mediavilla LA, Chew C, Campochiaro PA et al. Sequence and expression analysis of bovine pigment epithelium-derived factor. Biochim Biophys Acta 1998;1398:203-214.
36. Jun JH, Yoon WJ, Seo SB et al. BMP2-Activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity. J Biol Chem 2010;285:36410-36419.
37. Lai CF, Chaudhary L, Fausto A et al. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 2001;276:14443-14450.
38. Ge C, Xiao G, Jiang D et al. Critical role of the extracellular signalregulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol 2007;176:709-718.
39. Wang X, Harimoto K, Liu J et al. Spata4 promotes osteoblast differentiation through Erk-Activated Runx2 pathway. J Bone Miner Res 2011; 26:1964-1973.
40. Liu J, Chen L, Tao X et al. Phosphoinositide 3-kinase/Akt signaling is essential for prostaglandin E2-induced osteogenic differentiation of rat tendon stem cells. Biochem Biophys Res Commun 2013;435:514-519.
41. Pantovic A, Krstic A, Janjetovic K et al. Coordinated time-dependent modulation of AMPK/Akt/mTOR signaling and autophagy controls osteogenic differentiation of human mesenchymal stem cells. Bone 2013;52:524-531.
42. Choi YH, Jeong HM, Jin YH et al. Akt phosphorylates and regulates the osteogenic activity of Osterix. Biochem Biophys Res Commun 2011;411:637-641.
43. Rybchyn MS, Slater M, Conigrave AD et al. An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts. J Biol Chem 2011;286: 23771-23779.
44. Byon CH, Javed A, Dai Q et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 2008;283:15319-15327.
45. Jaiswal RK, Jaiswal N, Bruder SP et al. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-Activated protein kinase. J Biol Chem 2000;275: 9645-9652.
46. Schmidt C, Pommerenke H, Durr F et al. Mechanical stressing of integrin receptors induces enhanced tyrosine phosphorylation of cytoskeletally anchored proteins. J Biol Chem 1998;273:5081-5085.
47. Yao Y, Li W, Wu J et al. Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc Natl Acad Sci USA 2003;100:12759-12764.
48. Kao S, Jaiswal RK, Kolch W et al. Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem 2001;276:18169-18177.
49. Zetser A, Frank D, Bengal E. MAP kinase converts MyoD into an instructive muscle differentiation factor in Xenopus. Dev Biol 2001; 240:168-181.
50. Leloup L, Daury L, Mazeres G et al. Involvement of the ERK/MAP kinase signalling pathway in milli-calpain activation and myogenic cell migration. Int J Biochem Cell Biol 2007;39:1177-1189.
51. Li J, Zhao Z, Liu J et al. MEK/ERK and p38 MAPK regulate chondrogenesis of rat bone marrow mesenchymal stem cells through delicate interaction with TGF-beta1/Smads pathway. Cell Prolif 2010;43:333-343.
52. Bobick BE, Kulyk WM. MEK-ERK signaling plays diverse roles in the regulation of facial chondrogenesis. Exp Cell Res 2006;312:1079-1092.
53. Murakami S, Kan M, McKeehan WL et al. Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-Activated protein kinase pathway. Proc Natl Acad Sci USA 2000;97:1113-1118.
54. Wang Y, Gao R, Wang PP et al. The differential effects of aligned electrospun PHBHHx fibers on adipogenic and osteogenic potential of MSCs through the regulation of PPARgamma signaling. Biomaterials 2012;33:485-493.
55. Fuentes P, Acuna MJ, Cifuentes M et al. The anti-Adipogenic effect of angiotensin II on human preadipose cells involves ERK1,2 activation and PPARG phosphorylation. J Endocrinol 2010;206:75-83.
56. Qiao M, Shapiro P, Kumar R et al. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway. J Biol Chem 2004;279:42709-42718.
57. Wang C, Lin K, Chang J et al. Osteogenesis and angiogenesis induced by porous beta-CaSiO(3)/PDLGA composite scaffold via activation of AMPK/ERK1/2 and PI3K/Akt pathways. Biomaterials 2013;34:64-77.
58. Gharibi B, Ghuman MS, Hughes FJ. Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRbeta-induced MSC self-renewal. J Cell Mol Med 2012;16:2789-2801.
59. Tateishi K, Ashihara E, Honsho S et al. Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK- 3beta signaling. Biochem Biophys Res Commun 2007;352:635-641.